Plasma aldosterone is independently associated with the metabolic syndrome

被引:197
作者
Bochud, Murielle
Nussberger, Jurg
Bovet, Pascal
Maillard, Marc R.
Elston, Robert C.
Paccaud, Fred
Shamlaye, Conrad
Burnier, Michel
机构
[1] CHU Vaudois, Dept Med, Div Nephrol & Hypertens Consultat, CH-1011 Lausanne, Switzerland
[2] CHU Vaudois, Serv Nephrol, CH-1011 Lausanne, Switzerland
[3] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA
[4] Univ Lausanne, Inst Sociale & Prevent Med, Lausanne, Switzerland
[5] Minist Hlth, Victoria, Seychelles
关键词
aldosterone; metabolism; blood pressure; genetics;
D O I
10.1161/01.HYP.0000231338.41548.fc
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The aim of this study was to analyze the associations of plasma aldosterone and plasma renin activity with the metabolic syndrome and each of its components. We analyzed data from a family based study in the Seychelles made up of 356 participants (160 men and 196 women) from 69 families of African descent. In multivariable models, plasma aldosterone was associated positively (P < 0.05) with blood pressure in older individuals (interaction with age, P < 0.05) and with waist circumference in men (interaction with sex, P < 0.05) and negatively with high-density lipoprotein cholesterol, in particular in individuals with elevated urinary potassium excretion (interaction with urinary potassium, P < 0.05); plasma renin activity was significantly associated with triglycerides and fasting blood glucose. Plasma aldosterone, but not plasma renin activity, was associated with the metabolic syndrome per se, independently of the association with its separate components. The observation that plasma renin activity was associated with some components of the metabolic syndrome, whereas plasma aldosterone was associated with other components of the metabolic syndrome, suggests different underlying mechanisms. These findings reinforce previous observations associated with several cardiovascular risk factors and also suggest that aldosterone might suggesting that aldosterone is as contribute to the increased cardiovascular disease risk in individuals of African descent with the metabolic syndrome.
引用
收藏
页码:239 / 245
页数:7
相关论文
共 46 条
[41]   Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy - A randomized, double-masked, cross-over study [J].
Rossing, K ;
Schjoedt, KJ ;
Smidt, UM ;
Boomsma, F ;
Parving, HH .
DIABETES CARE, 2005, 28 (09) :2106-2112
[42]   Renin-angiotensin system inhibition prevents type 2 diabetes mellitus - Part 1. A meta-analysis of randomised clinical trials [J].
Scheen, AJ .
DIABETES & METABOLISM, 2004, 30 (06) :487-496
[43]   BLOOD-PRESSURE AND HORMONE CHANGES ASSOCIATED WITH WEIGHT-REDUCTION IN THE OBESE [J].
SOWERS, JR ;
NYBY, M ;
STERN, N ;
BECK, F ;
BARON, S ;
CATANIA, R ;
VLACHIS, N .
HYPERTENSION, 1982, 4 (05) :686-691
[44]   Is there a role for the ob gene product leptin in essential hypertension? [J].
Suter, PM ;
Locher, R ;
Hasler, E ;
Vetter, W .
AMERICAN JOURNAL OF HYPERTENSION, 1998, 11 (11) :1305-1311
[45]   Serum aldosterone and the incidence of hypertension in nonhypertensive persons [J].
Vasan, RS ;
Evans, JC ;
Larson, MG ;
Wilson, PWF ;
Meigs, JB ;
Rifai, N ;
Benjamin, EJ ;
Levy, D .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (01) :33-41
[46]  
2006, SAGE VERSION 5 0